MYNZ – mainz biomed n.v. - ordinary shares (US:NASDAQ)

News

Mainz Biomed Reports 2024 Financial Results and Provides Corporate Update
Mainz Biomed Enrolls First Patient in Its eAArly DETECT 2 Clinical Study
Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood Based Detection of Pancreatic Cancer
Colorectal Cancer Awareness Month: Mainz Biomed Advocates for a Shift from Screening to Prevention
Mainz Biomed Expands into Switzerland with labor team w
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com